Sun Pharmaceutical Industries Ltd.

•

sunpharma.comBSE: 524715NSE: SUNPHARMA

Market Cap₹ 4,41,958 Cr.

Current Price

High / Low₹ 2,047 / 1,548

Stock P/E147.6

Book Value₹ 98

Price to Book18.85

Dividend Yield0.87 %

ROCE13.3 %

ROE11.3 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 25.5% CAGR over last 5 years
Latest quarter profit grew 48.0% YoY, showing strong momentum
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.08x)
Company has a consistent dividend-paying track record
Company generates healthy free cash flow

CONS

Recent results are weak - TTM profit is down 47.4% versus prior year
A large part of profit comes from other income (47.8% of PBT)
Working capital days have increased from 9 to 179 days
Stock is trading at 18.8x its book value
Operating margins have contracted to 23.1% from 32.4%
Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY PHARMA NIFTYLARGEMIDCAP250 NIFTY100 LOWVOL30 NIFTY100 EQL WGT

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BIOCON	390.95	128.63	63712.89	0.13	136.80	53.36	4336.00	10.89	3.26	19.54

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	4,383	5,020	4,904	5,537	4,410	5,118	5,974	7,101	5,567	4,511	5,651	4,887	5,741
	3,517	3,719	3,866	3,746	3,737	3,919	4,476	4,120	3,900	3,846	4,092	3,595	4,363
Operating Profit	866	1,300	1,037	1,791	673	1,199	1,498	2,981	1,666	665	1,559	1,292	1,378
OPM %	19.76%	25.90%	21.15%	32.35%	15.26%	23.42%	25.07%	41.98%	29.93%	14.74%	27.59%	26.44%	24.00%
	14	116	159	119	83	224	69	132	6	554	84	63	172
Interest	158	194	215	218	216	259	231	232	223	248	244	217	278
Depreciation	415	393	400	393	370	297	303	305	299	336	339	326	308
Profit before Tax	390	907	751	1,402	258	871	1,240	2,654	1,185	672	1,097	849	1,486
Tax %	2.37%	1.97%	4.01%	38.11%	7.79%	3.73%	6.76%	23.05%	36.40%	16.01%	35.70%	28.30%	24.98%
Net Profit	381	889	721	868	238	838	1,156	2,042	754	564	705	609	1,115
	1.60	3.70	3.00	3.60	1.00	3.50	4.80	8.50	3.10	2.40	2.90	2.50	4.60

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	7,684	8,982	10,303	12,532	14,116	15,586	20,812	20,275	22,977	20,755	20,791
	7,745	8,128	8,562	9,820	11,859	12,917	14,390	14,775	16,395	15,968	15,897
Operating Profit	-61	855	1,742	2,712	2,257	2,669	6,423	5,500	6,583	4,787	4,894
OPM %	-0.79%	9.52%	16.90%	21.64%	15.99%	17.12%	30.86%	27.13%	28.65%	23.06%	23.54%
	690	301	72	1,511	103	-624	-2,608	334	634	1,267	873
Interest	224	388	541	408	268	388	472	784	954	948	988
Depreciation	422	487	553	562	1,236	1,350	1,601	1,601	1,287	1,312	1,309
Profit before Tax	-17	280	719	3,253	856	307	1,741	3,450	4,976	3,794	4,104
Tax %	-35.95%	-9.06%	-13.50%	1.29%	1.54%	132.58%	2.89%	17.15%	15.03%	30.86%	27.06%
Net Profit	-23	306	817	3,211	842	-100	1,691	2,858	4,228	2,623	2,994
EPS	-0.10	1.30	3.40	13.38	3.50	-0.40	7.00	11.91	17.62	10.93	—
Dividend Payout %	-3676.47%	157.00%	80.80%	29.89%	213.61%	-2399.81%	163.20%	113.33%	90.80%	146.33%	—

COMPOUNDED SALES GROWTH

10 Years:: 10%
5 Years:: 8%
3 Years:: 0%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 26%
3 Years:: 16%

STOCK PRICE CAGR

10 Years:: 9%
5 Years:: 19%
3 Years:: 17%
1 Year:: 14%

RETURN ON EQUITY

10 Years:: 7%
5 Years:: 10%
3 Years:: 14%
Last Year:: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	240	240	240	240	240	240	240	240	240	240
	20,770	22,083	22,604	24,156	26,699	24,348	23,508	23,454	23,660	22,131
	4,815	6,779	5,870	5,907	7,873	5,677	8,673	12,716	12,485	13,935
Trade Payables	2,073	2,566	2,155	2,129	4,029	2,710	3,126	2,620	3,470	3,533
	6,312	5,462	7,184	6,315	5,277	8,082	5,777	2,955	5,471	6,170
Total Liabilities	34,210	37,130	38,052	38,747	44,118	41,058	41,324	41,985	45,327	46,010
	4,039	4,645	4,978	5,229	9,669	9,713	8,712	7,737	7,372	7,613
Capital Work in Progress	1,055	830	456	384	459	359	329	388	708	652
	19,333	18,355	17,904	17,362	15,537	15,549	12,613	12,430	12,410	12,952
	2,308	2,136	2,793	2,634	3,423	3,404	3,989	3,424	3,934	4,302
	0	0	0	0	0	0	0	8,834	11,702	10,166
Cash & Bank	170	155	341	655	361	535	421	338	911	437
	7,304	11,009	11,580	12,484	14,668	11,498	15,260	8,834	8,289	9,887
Total Assets	34,210	37,130	38,052	38,747	44,118	41,058	41,324	41,985	45,327	46,010

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-837	-880	1,280	1,643	-179	5,477	939	-292	4,252	6,501
Cash from Investing	2,381	1,392	434	1,479	1,464	-2,702	-705	-263	-258	-1,381
Cash from Financing	-753	-272	-1,469	-2,871	-1,000	-4,871	169	474	-3,836	-5,230
	7	-52	207	-86	48	63	-29	-81	158	-110

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	54.48	54.48	54.48	54.48	54.48	54.48	54.48	54.48	54.48
	17.23	18.01	18.05	17.96	17.26	16.55	16.12	15.93	14.54
	19.17	18.48	18.43	18.58	19.38	20.12	20.72	21.00	22.06
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	9.02	8.90	8.93	8.87	8.77	8.73	8.58	8.48	8.82

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11

General Updates

2026-09-11 - Intimation under Regulation 30 of SEBI LODR

2026-09-09

General Updates

2026-09-09 - Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company

2026-09-08

Credit Rating- New

2026-09-08 - Sun Pharmaceutical Industries Limited has informed the Exchange about International Credit Ratings

2026-09-03

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-03 - Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

2026-09-01

Press Release

2026-09-01 - Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 01, 2026, titled "Sun Pharma Participates in White House Signing Ceremony Highlighting U.S. Medicines Pricing and Access Commitments".

2026-08-26

Copy of Newspaper Publication

2026-08-26 - Newspaper advertisements about Postal Ballot/E-Voting

2026-08-25

Shareholders meeting

2026-08-25 - Notice of Postal Ballot

2026-08-25

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

2026-08-17

General Updates

2026-08-17 - Update on Lipitor Antitrust Litigation